Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Stoevesandt

Showing results (11-20 of 12) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 12 results.
The British Journal of Dermatology|October 5, 2021
Treatment of pemphigus vulgaris and foliaceus with efgartigimod, a neonatal Fc receptor inhibitor: a phase II multicentre, open-label feasibility trialM Goebeler, Z Bata-Csörgő, C De Simone, et al.
Journal of Investigational Allergology & Clinical Immunology|November 8, 2023
Factors Affecting the Safety and Effectiveness of Venom ImmunotherapyL Arzt-Gradwohl, S A Herzog, W Aberer, et al.
Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
The British Journal of Dermatology|October 5, 2021
Treatment of pemphigus vulgaris and foliaceus with efgartigimod, a neonatal Fc receptor inhibitor: a phase II multicentre, open-label feasibility trialM Goebeler, Z Bata-Csörgő, C De Simone, et al.
Journal of Investigational Allergology & Clinical Immunology|November 8, 2023
Factors Affecting the Safety and Effectiveness of Venom ImmunotherapyL Arzt-Gradwohl, S A Herzog, W Aberer, et al.
Pageof 2